Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 32910814.
- Also identified by DOI 10.1093/cid/ciaa1361 and PMC identifier 8491833.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Adverse events are frequent in nontuberculous mycobacteria pulmonary disease treatment, but evidence to support their management is scarce. An expert panel survey on management of adverse events shows consistent opinions on management of hepatoxicity, ocular toxicity, ototoxicity, tinnitus, and gastrointestinal upset. These opinions can provide assistance in individual patient management decisions.
Medical subject headings
- Drug-Related Side Effects and Adverse Reactions
- Lung Diseases
- Mycobacterium Infections, Nontuberculous
- Mycobacterium avium-intracellulare Infection